Literature DB >> 26487277

Erratum to: A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.

Christian Vogelberg1, Petra Moroni-Zentgraf2, Migle Leonaviciute-Klimantaviciene3, Ralf Sigmund4, Eckard Hamelmann5, Michael Engel2, Stanley Szefler6.   

Abstract

Entities:  

Year:  2015        PMID： 26487277      PMCID： PMC4618361          DOI： 10.1186/s12931-015-0290-7

Source DB:  PubMed          Journal:  Respir Res        ISSN： 1465-9921


× No keyword cloud information.

Erratum

Following publication of our article [1] we identified an error in Fig. 5, where results were inadvertently switched between morning and evening PEF responses. The corrected Fig. 5 is provided in this erratum. The PEF results provided in our original article text remain correct.
Fig. 5

Morning and evening PEF response after 4 weeks of treatment (full analysis set). Adjusted for ‘treatment’, ‘period’, ‘patient’ and ‘baseline’. *p < 0.05 versus placebo Respimat®. PEF, peak expiratory flow

Morning and evening PEF response after 4 weeks of treatment (full analysis set). Adjusted for ‘treatment’, ‘period’, ‘patient’ and ‘baseline’. *p < 0.05 versus placebo Respimat®. PEF, peak expiratory flow
  1 in total

1.  A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.

Authors:  Christian Vogelberg; Petra Moroni-Zentgraf; Migle Leonaviciute-Klimantaviciene; Ralf Sigmund; Eckard Hamelmann; Michael Engel; Stanley Szefler
Journal:  Respir Res       Date:  2015-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.